trending Market Intelligence /marketintelligence/en/news-insights/trending/joufrhuda81ukqaaaqmmua2 content esgSubNav
In This List

Aspen, Mylan enter deal to distribute medicines in Australia, New Zealand

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Aspen, Mylan enter deal to distribute medicines in Australia, New Zealand

Aspen Pharmacare Holdings Ltd. and Mylan NV entered a deal to distribute certain prescription and over-the-counter products in Australia and New Zealand.

The agreement was struck between Canonsburg, Pa.-based Mylan, Aspen unit Aspen Global Inc. and the South African company's Australian subsidiaries, Aspen said in a filing.

The deal also includes an option by generics-maker Mylan to buy the portfolio of products for about A$188 million. The portfolio recorded sales of A$55 million for the year ended June 30.

Aspen Pharmacare develops specialty, branded and generic pharmaceutical products worldwide.